News – AmyriAD

News Releases

AmyriAD to Present Clinical and Preclinical Data at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

November 29, 2022

AmyriAD to Host a Key Opinion Leader Webinar on Alzheimer’s Disease Management

September 21, 2022

Pharma Company AmyriAD Steps into the Light with Phase III Symptom Relief Drug for Alzheimer’s Disease

November 10, 2021

ALL NEWS

Media Coverage

Sitting Down With… Sharon L Rogers, AmyriAD CEO, Renowned drug developer, 2023 Power Lister, and Olympic figure skating official

September 18, 2023

PharmaVoice Woman of the Week: AmyriAD Therapeutics’ Sharon Rogers

August 9, 2023

Women In Leadership: Sharon Rogers Ph.D. Creative and Tenacious In Fighting Alzheimer’s Disease

August 3, 2023

Neurology Live: The Potential of AD101 for Managing Symptoms of Alzheimer Disease

August 1, 2023

ALL MEDIA

UPCOMING EVENTS

There are currently no upcoming events. Stay tuned!

February 2, 2023

Feel free to contact us any time by email at info@amyriadtherapeutics.com

Past Events

Clinical Trials on Alzheimer’s Disease (CTAD)

November 29, 2022

November 29 – December 2, 2022 – 15th Clinical Trials on Alzheimer’s Disease (CTAD), San Francisco

KOL Event Hosted by AmyriAD Therapeutics

September 25, 2022

September 30, 2022 – Looking Beyond Amyloid for Alzheimer’s Disease: Combination Therapy, a Strategy Long Overdue. – KOL Event Hosted by AmyriAD Therapeutics.